Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc Sees Q3 2013 EPS Guidance Below Analysts' Expectation; Issues Q3 2013 Revenue Guidance Below Analysts' Estimates-Reuters


Thursday, 10 Oct 2013 08:31am EDT 

Reuters reported that Quest Diagnostics Inc estimated a third-quarter of 2013 profit below analysts' expectations, citing a fall in the number of tests ordered in the latter part of the quarter. The Company estimated adjusted earnings of $1.02 per share from continuing operations, down from $1.15 per share a year earlier. Quest also estimated revenue of $1.79 billion from continuing operations. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.83 billion and EPS of $1.17 for the third quarter of 2013. 

Company Quote

65.56
1.78 +2.79%
18 Dec 2014